McRae Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,984
| Closed | -$276K | – | 101 |
|
|
2022
Q2 | $276K | Buy |
2,984
+165
| +6% | +$15.3K | 0.07% | 88 |
|
|
2022
Q1 | $285K | Hold |
2,819
| – | – | 0.06% | 97 |
|
|
2021
Q4 | $291K | Sell |
2,819
-200
| -7% | -$20.6K | 0.06% | 98 |
|
|
2021
Q3 | $256K | Buy |
3,019
+200
| +7% | +$17K | 0.06% | 99 |
|
|
2021
Q2 | $235K | Buy |
2,819
+19
| +0.7% | +$1.58K | 0.05% | 101 |
|
|
2021
Q1 | $211K | Buy |
+2,800
| New | +$211K | 0.05% | 103 |
|
|
2020
Q1 | – | Sell |
-2,800
| Closed | -$208K | – | 90 |
|
|
2019
Q4 | $208K | Buy |
+2,800
| New | +$208K | 0.08% | 95 |
|
|
2019
Q1 | – | Sell |
-3,100
| Closed | -$203K | – | 92 |
|
|
2018
Q4 | $203K | Hold |
3,100
| – | – | 0.1% | 86 |
|
|
2018
Q3 | $244K | Buy |
+3,100
| New | +$244K | 0.1% | 86 |
|
|
2018
Q1 | – | Sell |
-3,100
| Closed | -$225K | – | 95 |
|
|
2017
Q4 | $225K | Hold |
3,100
| – | – | 0.09% | 85 |
|
|
2017
Q3 | $252K | Sell |
3,100
-243
| -7% | -$19.8K | 0.11% | 82 |
|
|
2017
Q2 | $269K | Hold |
3,343
| – | – | 0.11% | 81 |
|
|
2017
Q1 | $262K | Sell |
3,343
-39
| -1% | -$3.06K | 0.11% | 82 |
|
|
2016
Q4 | $267K | Hold |
3,382
| – | – | 0.12% | 84 |
|
|
2016
Q3 | $301K | Buy |
3,382
+82
| +2% | +$7.3K | 0.14% | 81 |
|
|
2016
Q2 | $316K | Hold |
3,300
| – | – | 0.15% | 77 |
|
|
2016
Q1 | $342K | Buy |
3,300
+200
| +6% | +$20.7K | 0.15% | 66 |
|
|
2015
Q4 | $303K | Hold |
3,100
| – | – | 0.15% | 60 |
|
|
2015
Q3 | $299K | Hold |
3,100
| – | – | 0.15% | 59 |
|
|
2015
Q2 | $325K | Hold |
3,100
| – | – | 0.15% | 57 |
|
|
2015
Q1 | $320K | Hold |
3,100
| – | – | 0.15% | 57 |
|
|
2014
Q4 | $299K | Hold |
3,100
| – | – | 0.14% | 63 |
|
|
2014
Q3 | $247K | Hold |
3,100
| – | – | 0.12% | 67 |
|
|
2014
Q2 | $234K | Hold |
3,100
| – | – | 0.11% | 69 |
|
|
2014
Q1 | $232K | Hold |
3,100
| – | – | 0.12% | 67 |
|
|
2013
Q4 | $222K | Buy |
+3,100
| New | +$222K | 0.11% | 68 |
|